gptkbp:instance_of
|
gptkb:legal_case
|
gptkbp:analysis
|
ongoing
|
gptkbp:calls_for
|
gptkb:hospital
company executives
|
gptkbp:case_types
|
extensive records
|
gptkbp:clinical_trial
|
gptkb:legal_case
several weeks
|
gptkbp:community_engagement
|
high
|
gptkbp:consequences
|
corporate accountability
far-reaching
potential fines
|
gptkbp:court
|
gptkb:Johnson_&_Johnson
gptkb:New_Jersey_Superior_Court
gptkb:State_of_New_Jersey
gptkb:battle
no liability
defensive litigation
harm caused by opioids
|
gptkbp:duration
|
high
|
gptkbp:effective_date
|
gptkb:2018
|
gptkbp:exhibited_at
|
marketing documents
|
gptkbp:feedback
|
mixed opinions
|
gptkbp:finish
|
made by both sides
|
gptkbp:future_plans
|
gptkb:significant
|
gptkbp:has_member
|
held prior to trial
|
gptkbp:historical_debate
|
compliance with regulations
deceptive marketing practices
|
https://www.w3.org/2000/01/rdf-schema#label
|
State v. Johnson & Johnson
|
gptkbp:impact
|
public health
|
gptkbp:involves
|
gptkb:Johnson_&_Johnson
gptkb:State_of_New_Jersey
|
gptkbp:judges
|
used in trial
Judge Mc Geady
|
gptkbp:judging_criteria
|
to be determined
|
gptkbp:judicial_review
|
gptkb:battle
|
gptkbp:jurisdiction
|
gptkb:New_Jersey
|
gptkbp:legal_issue
|
consumer protection
long-term litigation
|
gptkbp:legal_representation
|
State Attorney General
|
gptkbp:legislation
|
potential changes in law
|
gptkbp:major_city
|
ongoing
not reached
|
gptkbp:media_coverage
|
extensive
|
gptkbp:opened
|
made by both sides
|
gptkbp:outcome
|
gptkb:memorial
pending
analyzed by legal experts
awaiting verdict
|
gptkbp:precedent
|
potential impact on future cases
could influence future litigation
|
gptkbp:public_awareness
|
increased
|
gptkbp:public_perception
|
highly publicized
|
gptkbp:related_to
|
opioid crisis
|
gptkbp:state
|
negligence
aggressive enforcement
|
gptkbp:tactics
|
denial of wrongdoing
|
gptkbp:year
|
gptkb:2021
|
gptkbp:bfsParent
|
gptkb:Minnesota_State_Attorney_General
|
gptkbp:bfsLayer
|
5
|